O

Otsuka Pharmaceutical

Global pharma maker of Abilify

Associate Director - Analytical, Structural Characterization

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timePrinceton, NJ, USAIn-person

About the Job

Requirements

  • A PhD in Analytical Chemistry, Organic Chemistry, Pharmaceutical Sciences, or a related discipline, or an MS with significant and progressive industry experience.
  • 8–10+ years of experience in small molecule analytical development in the pharmaceutical or biotech industry.
  • Demonstrated expertise in structural elucidation, impurity characterization, and solid-state chemistry.
  • Experience supporting CMC development and regulatory submissions, including IND and NDA.
  • Deep understanding of small molecule chemistry and analytical control strategies.
  • Strong problem-solving, troubleshooting, and data interpretation capabilities.
  • Ability to communicate complex analytical concepts to cross-functional and executive stakeholders.
  • Experience working in GxP-regulated environments.
  • Comfort operating in a resource-conscious, fast-moving small company setting.

Responsibilities

  • Lead the scientific strategy and execution of small molecule structural characterization across all phases of development, from early discovery support through commercial lifecycle management.
  • Ensure comprehensive understanding and control of molecular structure, impurities, solid-state form, and degradation behavior to support process development, formulation, regulatory submissions, and commercialization.
  • Provide subject matter expertise for small molecule structural characterization, including molecular identity, impurity profiling, degradation pathways, and solid-state properties.
  • Define and execute analytical strategies to support process development, scale-up, comparability, and lifecycle management.
  • Lead investigation and resolution of complex analytical and CMC issues related to structure, impurities, and stability.
  • Interpret and integrate analytical data to guide critical CMC and development decisions.
  • Oversee development, qualification, and validation of methods including NMR (1D/2D), MS (LC-MS, HRMS), IR, Raman, UV, HPLC/UPLC (reverse phase, normal phase, chiral), GC, forced degradation, extractables/leachables, genotoxic impurities, XRPD, DSC, TGA, DVS, microscopy, polymorph screening, and salt screening.
  • Drive adoption of fit-for-purpose methods aligned with development stage and regulatory expectations.
  • Support CMC strategies for IND, NDA, and post-approval submissions, including impurity justification and solid-form control.
  • Author, review, and approve analytical sections of regulatory documents and responses to health authority questions.
  • Ensure analytical approaches comply with ICH, FDA, and global regulatory guidance for small molecules.
  • Contribute to setting specifications, control strategies, and stability programs.
  • Partner closely with Process Chemistry, Formulation, Manufacturing, Quality, and Regulatory Affairs teams.
  • Support selection and control of API solid form and formulation-relevant attributes.
  • Manage and oversee work performed by external CROs, CDMOs, and analytical vendors.
  • Provide project leadership, ensuring analytical deliverables are met on time and with high quality.
  • Contribute to departmental planning, budgeting, and continuous improvement initiatives.
  • Establish scalable analytical processes appropriate for a growing organization.

Desired Qualifications

  • Prior people leadership or strong matrix leadership experience.

About the Company

Otsuka Pharmaceutical

Global pharma maker of Abilify

Otsuka Pharmaceutical develops and markets medicines and health products worldwide, including prescription drugs and nutraceutical beverages. Its product lineup ranges from pharmaceutical treatments such as Abilify (an antipsychotic) to consumer health drinks like Pocari Sweat, which helps replenish electrolytes. Abilify works as a psychiatric medication used to treat conditions such as schizophrenia and bipolar disorder, while Pocari Sweat is an ion-replacement beverage designed to restore minerals and fluids after activity or heat. The company differentiates itself through a long history dating back to its founding in 1921, a broad, globally scaled portfolio spanning drugs and health beverages, and a focus on health improvements across populations. Its stated goal is to create new products for better health worldwide.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Tokyo, Japan
Founded
1921

Recently Posted Jobs

Explore more opportunities at Otsuka Pharmaceutical

See more jobs